Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Anticancer Research
|
June 9, 2001
Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract
M Hejna, G Hamilton, T Brodowicz, et al.
Sarcoma
|
June 4, 2008
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
T Brodowicz, E Schwameis, J Widder, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 4, 1999
Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression
A Spittler, C M Reissner, R Oehler, et al.
Cancer Immunology, Immunotherapy : CII
|
September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study Group
M Schmidinger, G G Steger, C Wenzel, et al.
British Journal of Cancer
|
December 18, 2001
Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
T Brodowicz, D Kandioler, S Tomek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 24, 2003
Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines
S Tomek, W Koestler, P Horak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2013
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)
C Obasaju, L Bowman, P Wang, et al.
International Journal of Cancer
|
September 27, 2000
Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer
R M Wolfram, A C Budinsky, T Brodowicz, et al.
Oncology
|
April 15, 1999
Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer
M Raderer, M H Hejna, J B Valencak, et al.
Anti-Cancer Drugs
|
November 18, 2000
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
T Brodowicz, R M Wolfram, W J Köstler, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Anticancer Research
|
June 9, 2001
Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract
M Hejna, G Hamilton, T Brodowicz, et al.
Sarcoma
|
June 4, 2008
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
T Brodowicz, E Schwameis, J Widder, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 4, 1999
Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression
A Spittler, C M Reissner, R Oehler, et al.
Cancer Immunology, Immunotherapy : CII
|
September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study Group
M Schmidinger, G G Steger, C Wenzel, et al.
British Journal of Cancer
|
December 18, 2001
Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
T Brodowicz, D Kandioler, S Tomek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 24, 2003
Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines
S Tomek, W Koestler, P Horak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2013
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)
C Obasaju, L Bowman, P Wang, et al.
International Journal of Cancer
|
September 27, 2000
Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer
R M Wolfram, A C Budinsky, T Brodowicz, et al.
Oncology
|
April 15, 1999
Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer
M Raderer, M H Hejna, J B Valencak, et al.
Anti-Cancer Drugs
|
November 18, 2000
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
T Brodowicz, R M Wolfram, W J Köstler, et al.
Page
of 6